Western blot analysis corroborated these findings, showing that OPTN overexpression reduced the protein levels of OPTN, LC3BII/I, cleaved Caspase‐9, and cleaved Caspase‐3 in SL‐treated GBM cells (Figure 3D; Figure S11B, Supporting Information). This evidence concerns the gene OPTN and glioblastoma.